EUVIMEDEUVIMED entdecken
Open Access

APOE + macrophages and POSTN + CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma

Qintao Ge iD, Shengdong Ge iD, Zhongyuan Wang iD, Aihetaimujiang Anwaier iD, Jiahe Lu iD, Xi Tian iD, Yue Wang, Jianfeng Yang iD, Yonghao Chen iD, Hailiang Zhang iD, Dingwei Ye iD, Shan-Chao Zhao iD und 1 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aed0733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Qintao Ge und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences,…. Hauptthemen laut MEDLINE: Kidney Neoplasms, Carcinoma, Renal Cell, Apolipoproteins E, Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor immune barriers (TIBs) are spatially organized stromal-immune niches that restrict lymphocyte entry. To explain persistent immune-checkpoint blockade (ICB) resistance in clear cell renal cell carcinoma (ccRCC), we mapped TIBs and defined a peritumoral variant built from POSTN + cancer-associated fibroblasts (CAFs) interlaced with APOE + tumor-associated macrophages (TAMs). This niche excluded CD8 + T cells from tumor cores, and was enriched in poor-prognosis, ICB-refractory patients. Spatial transcriptomics and single-cell profiling showed TIB regions enriched for extracellular-matrix remodeling, immunosuppressive ligand-receptor circuits, and metabolic reprogramming. Mechanistically, tumor-derived TGF-β1 activated CAFs via SMAD signaling, inducing POSTN and recruiting APOE + TAMs through integrin and chemokine axes. TAMs secreted TGF-β1 and VEGFA, amplifying stromal programs and sustaining exclusion. Blocking POSTN reprogrammed macrophages, reduced matrix-mediated suppression, and restored CD8 + infiltration. In vivo, POSTN inhibition combined with ICB boosted antitumor immunity, reduced tumor burden, and reversed immunosuppressive infiltration, nominating POSTN-directed strategies to potentiate ICB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsCarcinoma, Renal CellApolipoproteins EMacrophagesCancer-Associated FibroblastsTumor-Associated MacrophagesDrug Resistance, NeoplasmPeriostinHumansAnimalsMiceTumor MicroenvironmentTransforming Growth Factor beta1ImmunotherapyImmune Checkpoint InhibitorsCell Adhesion Molecules

Substanzen

PeriostinPOSTN protein, humanApolipoproteins ETransforming Growth Factor beta1Immune Checkpoint InhibitorsCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Urology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College; Qingdao Institute of Life Sciences, Fudan University, Shanghai, 200032, P.R. China.
  • Shanghai Genitourinary Cancer Institute, Shanghai, 200032 P.R. China.
  • Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, 510900, China.
  • Department of Urology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, P.R. China.
  • West China Medical Center of Sichuan University, Chengdu, Sichuan, 610000, P.R. China.
  • Department of Urology, Huadong Hospital, Fudan University, Shanghai 200030, China.

ORCID-Profile: Qintao Ge, Shengdong Ge, Zhongyuan Wang, Aihetaimujiang Anwaier, Jiahe Lu, Xi Tian, Jianfeng Yang, Yonghao Chen, Hailiang Zhang, Dingwei Ye, Shan-Chao Zhao, Wenhao Xu

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Shanghai
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • Shanghai Hospital Development Center
  • Beijing Xisike Clinical Oncology Research Foundation
  • Zhongnanshan Medical Foundation of Guangdong Province

Zitieren

APA

Ge, Q., Ge, S., Wang, Z., Anwaier, A., Lu, J., Tian, X., Wang, Y., Yang, J., Chen, Y., Zhang, H., Ye, D., Zhao, S. C., & Xu, W. (2026). APOE + macrophages and POSTN + CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma. Science Advances. https://doi.org/10.1126/sciadv.aed0733

Vancouver

Ge Q, Ge S, Wang Z, Anwaier A, Lu J, Tian X, et al. APOE + macrophages and POSTN + CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma. Science Advances. 2026. doi:10.1126/sciadv.aed0733

BibTeX
@article{Ge2026,
  author = {Ge, Qintao and Ge, Shengdong and Wang, Zhongyuan and Anwaier, Aihetaimujiang and Lu, Jiahe and Tian, Xi and Wang, Yue and Yang, Jianfeng and Chen, Yonghao and Zhang, Hailiang and Ye, Dingwei and Zhao, Shan-Chao and Xu, Wenhao},
  title = {APOE + macrophages and POSTN + CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aed0733}
}
Kostenlos starten →